12 Feb 2025
22:15 CET |
NANOBIOTIX |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
|
20103010 Biotechnology |
Share history |
12 Feb 2025
22:15 CET |
NANOBIOTIX |
Voting Rights and Shares Capital of the Company
|
20103010 Biotechnology |
Share history |
12 Feb 2025
20:00 CET |
AVENTADOR |
Availability of the 2024 Half-Year Financial Report
|
45201010 Food Retailers and Wholesalers |
Legal |
12 Feb 2025
20:00 CET |
AVENTADOR |
Mise à disposition du Rapport Financier Semestriel 2024
|
45201010 Food Retailers and Wholesalers |
Legal |
12 Feb 2025
19:02 CET |
CARMILA |
Carmila: Lancement d’un programme de rachat d’actions pour 10 millions d’euros
|
35102045 Retail REITs |
Other subject |
12 Feb 2025
19:02 CET |
CARMILA |
Carmila: Launch of a Share Buyback Program for €10 Million
|
35102045 Retail REITs |
Other subject |
12 Feb 2025
18:58 CET |
SAFRAN |
Déclaration du nombre d\'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2025
|
50201010 Aerospace |
Other subject |
12 Feb 2025
18:58 CET |
SAFRAN |
Statement about the number of shares composing the share capital and the number of voting rights as at January 31, 2025
|
50201010 Aerospace |
Other subject |
12 Feb 2025
18:50 CET |
VOLTALIA |
Voltalia awarded by Sustainalytics “Top-Rated Industry” distinction for its ESG performance
|
65101010 Alternative Electricity |
Other subject |
12 Feb 2025
18:50 CET |
VOLTALIA |
Voltalia obtient la distinction « Top-Rated Industry » de Sustainalytics pour sa performance ESG
|
65101010 Alternative Electricity |
Other subject |
12 Feb 2025
18:33 CET |
SAFE |
SAFE GROUP - CHIFFRE D’AFFAIRES 2024
|
20102015 Medical Supplies |
- |
12 Feb 2025
18:28 CET |
UBISOFT ENTERTAINMENT |
Informations sur les droits de vote et les actions au 31 janvier 2025
|
40203040 Electronic Entertainment |
Other subject |
12 Feb 2025
18:26 CET |
UNIBAIL-RODAMCO-WESTFIELD |
Meeting of the Supervisory Board of Unibail-Rodamco-Westfield on February 12, 2025
|
35102045 Retail REITs |
General meeting / Board Meeting |
12 Feb 2025
18:13 CET |
ACCOR |
Déclaration d’actions et de droits de vote - 31/01/2025
|
40501025 Hotels and Motels |
Other subject |
12 Feb 2025
18:13 CET |
ACCOR |
Disclosure of Share Capital and Voting Rights - 01.31.2025
|
40501025 Hotels and Motels |
Other subject |
12 Feb 2025
18:00 CET |
PRODWAYS GROUP |
Chiffre d'affaires 2024 : des revenus stables sur une base comparable
|
50204050 Machinery: Specialty |
Sales, Income |
12 Feb 2025
18:00 CET |
LECTRA |
LECTRA : Des résultats 2024 en progression dans un environnement toujours dégradé
|
10101015 Software |
Income |
12 Feb 2025
18:00 CET |
SPINEGUARD |
SpineGuard : Bilan semestriel du contrat de liquidité contracté avec la société de bourse TSAF
|
20102010 Medical Equipment |
Legal |
12 Feb 2025
18:00 CET |
BIGBEN INTERACTIVE |
BIGBEN: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
|
40203040 Electronic Entertainment |
Share history |
12 Feb 2025
18:00 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Risultati del quarto trimestre e del 2024 - Solida crescita del fatturato e margini in espansione nel 2024. Smart glasses nuovo motore della crescita, Nuance pronto per un esordio promettente
|
20102015 Medical Supplies |
Commercial results |
12 Feb 2025
18:00 CET |
REXEL |
Rexel: Board of Directors - Renewal of three Directors and of the Chief Executive Officer
|
50202010 Electrical Components |
General meeting / Board Meeting |
12 Feb 2025
18:00 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Q4/FY 2024 Results - Sound sales growth and margin expansion in 2024. Smartglasses as a new driver, Nuance off to a promising start
|
20102015 Medical Supplies |
Commercial results |
12 Feb 2025
18:00 CET |
PRODWAYS GROUP |
Activity 2024: stable revenues on a comparable basis
|
50204050 Machinery: Specialty |
Sales, Income |
12 Feb 2025
18:00 CET |
LECTRA |
LECTRA: Q4 and Full Year 2024 financial report available
|
10101015 Software |
Income |
12 Feb 2025
18:00 CET |
GETLINK SE |
Getlink SE : Information relative au nombre total des droits de vote existants et d’actions composant le capital social – Avis mentionné à l’article L. 233-8 II du Code de commerce
|
50206020 Railroads |
Other subject |
12 Feb 2025
18:00 CET |
LECTRA |
LECTRA: 2024: improved financial results in what remains a degraded environment
|
10101015 Software |
Income |
12 Feb 2025
18:00 CET |
GETLINK SE |
Getlink SE: Information Relating to the Total Number of Shares and Voting Rights Which Form the Share Capital – Notice Referred to Under Article L. 233-8 II of the French Commercial Code
|
50206020 Railroads |
Other subject |
12 Feb 2025
18:00 CET |
REXEL |
Rexel - Conseil d'administration : Renouvellement de trois administrateurs et du Directeur Général
|
50202010 Electrical Components |
General meeting / Board Meeting |
12 Feb 2025
18:00 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Résultats T4 et annuels 2024 - Solide croissance du chiffre d’affaires et augmentation de la marge en 2024. Un nouveau vecteur de croissance : les lunettes connectées, débuts prometteurs de Nuance Audio
|
20102015 Medical Supplies |
Commercial results |
12 Feb 2025
18:00 CET |
SAVENCIA S.A. |
Savencia : actions et droits de vote- information mensuelle
|
45102020 Food Products |
Other subject |
12 Feb 2025
18:00 CET |
LECTRA |
LECTRA : Mise à disposition du rapport sur l'activité et les comptes consolidés du quatrième trimestre et de l’exercice 2024
|
10101015 Software |
Income |
12 Feb 2025
17:54 CET |
SOCIETE GENERALE |
Societe Generale: shares and voting rights as of 31 January 2025
|
30101010 Banks |
Share history |
12 Feb 2025
17:54 CET |
SOCIETE GENERALE |
Société Générale : actions et droits de vote au 31 janvier 2025
|
30101010 Banks |
Share history |
12 Feb 2025
17:45 CET |
MICHELIN |
Michelin delivered segment operating income of €3.4 billion in 2024 and generated a free cash flow of €2.2 billion, demonstrating its ability to adapt to uncertain market conditions.
|
40101015 Tires |
Income |
12 Feb 2025
17:45 CET |
MICHELIN |
Démontrant sa capacité à s’adapter à des marchés incertains, Michelin enregistre en 2024 un résultat opérationnel des secteurs de 3,4 milliards € et un cash-flow libre de 2,2 milliards €.
|
40101015 Tires |
Income |
12 Feb 2025
17:45 CET |
FIGEAC AERO |
FIGEAC AÉRO: AGENDA FINANCIER
|
50201010 Aerospace |
Meetings / events |
12 Feb 2025
17:45 CET |
IMERYS |
Imerys-press-release-Rating-CDP-12-02-2025-VENG
|
55102000 General Mining |
Corporate life |
12 Feb 2025
17:45 CET |
FIGEAC AERO |
FIGEAC AÉRO: FINANCIAL CALENDAR
|
50201010 Aerospace |
Meetings / events |
12 Feb 2025
17:45 CET |
IMERYS |
Imerys-communiqué-de-presse-notation-CDP-12-02-2025-VFR
|
55102000 General Mining |
Corporate life |
12 Feb 2025
17:45 CET |
CERINNOV GROUP |
Cerinnov Group: Calendrier de communication financière 2025
|
50204000 Machinery: Industrial |
Corporate life, Other subject |
12 Feb 2025
17:45 CET |
REXEL |
Rexel: Q4 sales & FY 2024 results
|
50202010 Electrical Components |
Income |
12 Feb 2025
17:45 CET |
KLEPIERRE |
KLÉPIERRE: STRONG 2024 OUTPERFORMANCE WITH POSITIVE OUTLOOK FOR 2025
|
35102045 Retail REITs |
Commercial results |
12 Feb 2025
17:45 CET |
MCPHY ENERGY |
McPhy Energy: Financial calendar for 2025
|
60102020 Renewable Energy Equipment |
Legal |
12 Feb 2025
17:45 CET |
RUBIS |
RUBIS: Launch of an employees shareholding plan “Rubis Avenir 2025”
|
40401030 Specialty Retailers |
Change in Capital |
12 Feb 2025
17:45 CET |
REXEL |
Rexel : Ventes du T4 & résultats 2024
|
50202010 Electrical Components |
Income |
12 Feb 2025
17:45 CET |
KLEPIERRE |
KLÉPIERRE: SOLIDE SURPERFORMANCE EN 2024 ET PERSPECTIVES POSITIVES POUR 2025
|
35102045 Retail REITs |
Commercial results |
12 Feb 2025
17:45 CET |
MCPHY ENERGY |
McPhy Energy : Agenda financier 2025
|
60102020 Renewable Energy Equipment |
Legal |
12 Feb 2025
17:45 CET |
RUBIS |
RUBIS: Lancement d’une opération d’actionnariat salarié « Rubis Avenir 2025 »
|
40401030 Specialty Retailers |
Change in Capital |
12 Feb 2025
17:44 CET |
CASINO GUICHARD |
Groupe Casino - Nombre de droits de vote et d'actions 31-01-2025
|
45201010 Food Retailers and Wholesalers |
New |
12 Feb 2025
17:40 CET |
EIFFAGE |
Eiffage wins in consortium the design-build contract for the Institute of Biology and Pathology of the Bordeaux University Hospital in a deal worth €50.8 million
|
50101010 Construction |
Other subject |